Content available soon!

• Identifying and Planning for Individualized Change: Patient-Provider Collaboration Using Lightweight Food Diaries in Healthy Eating and Irritable Bowel Syndrome

• Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)

• Gastrointestinal symptoms - an illness burden that affects daily work in patients with IBS

• Gender-based Differences among 1990-1991 Gulf War Era Veterans: Demographics, Lifestyle Behaviors, and Health Conditions

• Irritable bowel syndrome: a new therapeutic target when treating obesity?

• Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer

• Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria

• Role of brain imaging in disorders of brain-gut interaction: a Rome Working Team Report

• The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea

• Increased Gut Permeability in First-degree Relatives of Children with Irritable Bowel Syndrome or Functional Abdominal Pain

• Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E

• Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome

• Irritable Bowel Syndrome is Underdiagnosed and Ineffectively Managed Among Endurance Athletes

• Update on Pharmacotherapy for Irritable Bowel Syndrome

• Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?

• Noninvasive Diagnosis of Irritable Bowel Syndrome via Bowel Sound Features: Proof of Concept

• Should We Use Tegaserod for Irritable Bowel Syndrome?

• The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study

• Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

• Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome

• Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy

• Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease

• Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials

• Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome

• Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome

• Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome

• Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis

• Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review

• Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan

• Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course

• Primary healthcare utilisation and self-rated health among patients with Irritable Bowel Syndrome: What are the impacts of comorbidities, gastrointestinal symptom burden, sense of coherence and stress?

• Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?

• Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review

• Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents

• Gut Microbiota in Patients With Irritable Bowel Syndrome-a Systematic Review

• Irritable Bowel Syndrome and Dietary Interventions

• Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy

• Prucalopride for the treatment of constipation: a view from 2015 and beyond

• Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia

• Integrating psychosocial approaches into the management of childhood functional gastrointestinal disorders: a role for social work

• Altered Brain Structure and Functional Connectivity and Its Relation to Pain Perception in Girls With Irritable Bowel Syndrome

• SKYPE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME: Effectiveness and Comparison with Face-to-Face Treatment

• Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey

• Efficacy of the gluten free diet in the management of functional gastrointestinal disorders: a systematic review on behalf of the Italian Society of Paediatrics

• Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome

• Nonpharmacologic options for treating irritable bowel syndrome

• Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome

• The overlap of irritable bowel syndrome and noncoeliac gluten sensitivity

• Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis

• Risk factors for upper and lower functional gastrointestinal disorders in Persian Gulf War Veterans during and post-deployment

• Conditioned Pain Modulation (CPM) is Reduced in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of CPM and the Role of Psychological Factors

• Overlapping irritable bowel syndrome and inflammatory bowel disease

• Elimination Diets for Irritable Bowel Syndrome: Approaching the End of the Beginning

• Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

• The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data

• Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study

• Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study

• Negative Events During Adulthood are Associated With Symptom Severity and Altered Stress Response in Patients With Irritable Bowel Syndrome

• Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms

• Fibromyalgia and Irritable Bowel Syndrome in Female Pelvic Pain

• Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome

• Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome

• Plecanatide for Treatment of Chronic Constipation and Irritable Bowel Syndrome

• Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders

• Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial

• Multiple psychological factors predict abdominal pain severity in children with irritable bowel syndrome

• Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities

• Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research

• Montezuma's revenge - the sequel: The one-hundred year anniversary of the first description of "post-infectious" irritable bowel syndrome

• Probiotics in irritable bowel syndrome: Where are we?

• Irritable Bowel Syndrome: What Treatments Really Work

• Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review

• Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up

• Pediatric Integrative Medicine in Academia: Stanford Children's Experience

• A review of the gluten-free diet in non-celiac patients: beliefs, truths, advantages and disadvantages

• Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome

• Management Options for Irritable Bowel Syndrome

• Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?

• Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review

• Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors

• Update on Dietary Management of Childhood Functional Abdominal Pain Disorders

• Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials

• Gluten-Free Diet and Its 'Cousins' in Irritable Bowel Syndrome

• Association of Fatigue With TPH2 Genetic Polymorphisms in Women With Irritable Bowel Syndrome

• UK clinical experience up to 52?weeks with linaclotide for irritable bowel syndrome with constipation

• Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome

• Symptomatology Correlations Between the Diaphragm and Irritable Bowel Syndrome

• A Protocol-Driven Assessment Promotes a More Accurate Diagnosis of Irritable Bowel Syndrome

• Changing Beliefs About Emotions in IBS: A Single Case Design

• Irritable bowel syndrome following Clostridium difficile infection

• Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study

• Probiotics in Disease Prevention and Treatment

• Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome

• Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review

• The Role of Fiber in the Treatment of Functional Gastrointestinal Disorders in Children

• Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

• Declining Rates of Referral for Irritable Bowel Syndrome Without Constipation at a Tertiary Care Center

• Linaclotide increases cecal pH, accelerates colonic transit, and increases colonic motility in irritable bowel syndrome with constipation.

• Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation

• Influence of Dietary Restriction on Irritable Bowel Syndrome

• Naturopathic Approaches to Irritable Bowel Syndrome-A Delphi Study

• Fecal microbiota transfer for bowel disorders: efficacy or hype?

• Clinical application of dietary therapies in irritable bowel syndrome

• Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

• Pre- and perinatal stress and irritable bowel syndrome in young adults - A nationwide register-based cohort study

• Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

• Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey

• Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome

• The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea

• Symptoms and dietary practices of irritable bowel syndrome patients compared to controls: results of a United States National survey

• A Randomized Trial of a Group-Based Integrative Medicine Approach Compared to Waitlist Control on Irritable Bowel Syndrome Symptoms in Adults

• Questionnaire on Irritable Bowel Syndrome and Symptom Management Among Endurance Athletes Is Valid and Reliable

• Reduced Symptoms of Post-traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans

• Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis

• Pre- and probiotic overview

• Review article: an analysis of safety profiles of the treatments for diarrhoea-predominant irritable bowel syndrome

• Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis

• Potential role of the common food additive manufactured citric acid in eliciting significant inflammatory reactions contributing to serious disease states: A series of four case reports

• Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease

• Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic

• Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome

• Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome

• A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome

• Association between 2 painful and poorly understood conditions: irritable bowel and sensitive skin syndromes

• The gut microbiome and irritable bowel syndrome

• Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists

• Wheat Intolerance and Chronic Gastrointestinal Symptoms in an Australian Population-based Study: Association Between Wheat Sensitivity, Celiac Disease and Functional Gastrointestinal Disorders

• Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics

• Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease

• The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs

• Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome

• Quality Improvement in Gastroenterology: A Systematic Review of Practical Interventions for Clinicians

• Ambivalence over emotional expression and perceived social constraints as moderators of relaxation training and emotional awareness and expression training for irritable bowel syndrome

• Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study

• Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

• Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis

• A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study

• Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine

• Implications of Pharmacogenomics to the Management of IBS

• The "Biology-First" Hypothesis: Functional disorders may begin and end with biology-A scoping review

• Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome

• Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States

• Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome

• Use of Sourdough in Low FODMAP Baking

• No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease

• Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire

• Refractory Constipation: What is the Clinician to Do?

• Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome

• Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome

• Implications of Pharmacogenomics to the Management of IBS

• Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study

• Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review

• Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome

• Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics

• The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs

• Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine

• Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

• Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation

• Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update

• The role of avoidance behavior in the treatment of adolescents with irritable bowel syndrome: A mediation analysis

• Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review

• Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome

• Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study

• Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome

• Pediatric Irritable Bowel Syndrome: Perspectives on Pain and Adolescent Social Functioning

• No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease

• Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States

• Pediatric irritable bowel syndrome and other functional abdominal pain disorders: an update of non-pharmacological treatments

• Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

• Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms

• Connecting Our Gut Feeling and How Our Gut Feels: The Role of Well-being Attributes in Irritable Bowel Syndrome

• Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea

• Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study

• Health problems associated with irritable bowel syndrome: analysis of a primary care registry

• Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome

• Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview

• Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus

• Functional Bowel Disorders Gastroenterology's 75th anniversary

• Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials

• Functional Gastrointestinal Disorders: Functional Lower Gastrointestinal Disorders in Adults

• Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Santé study

• Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals

• Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation

• Development of Irritable Bowel Syndrome Features Over a 5-year Period

• Desperately seeking a cure: Treatment seeking and appraisal in irritable bowel syndrome

• The efficacy of telehealth delivered educational approaches for patients with chronic diseases: A systematic review

• Gut Microbiota-Based Therapies for Irritable Bowel Syndrome

• Fermentable short chain carbohydrate (FODMAP) content of common plant-based foods and processed foods suitable for vegetarian- and vegan-based eating patterns

• Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV

• Research Design Characteristics of Published Pharmacologic Randomized Clinical Trials for Irritable Bowel Syndrome and Chronic Pelvic Pain Conditions: an Acttion Systemic Review

• Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis

• The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review

• Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome

• Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome

• Linaclotide in Irritable Bowel Syndrome with Constipation: A Phase 3 Randomized Trial in China and Other Regions

• Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution

• The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice

• Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study

• Layperson's knowledge and perceptions of irritable bowel syndrome as potential barriers to care

• Best uses of osteopathic manipulation

• Positive and negative affect mediate the bidirectional relationship between emotional processing and symptom severity and impact in irritable bowel syndrome

• Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know?

• The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome

• Evidence-based management of irritable bowel syndrome with diarrhea

• Wake-up Call to Clinicians: The Impact of Sleep Dysfunction on Gastrointestinal Health and Disease

• Number of retained radiopaque markers on a colonic transit study does not correlate with symptom severity or quality of life in chronic constipation

• Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide

• The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report

• Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research

• New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond

• Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study

• The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome(IBS)

• Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education

• The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update

• Stress & the gut-brain axis: Regulation by the microbiome

• Doctor-patient relationship and quality of life in Irritable Bowel Syndrome: an exploratory study of the potential mediating role of illness perceptions and acceptance

• Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?

• Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry?

• Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial

• Celiac disease is uncommon in irritable bowel syndrome in the USA

• An update on prucalopride in the treatment of chronic constipation

• Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis

• Medicinal Foods for Functional GI Disorders

• Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment

• Gender and Weight Influence Quality of Life in Irritable Bowel Syndrome

• Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions

• Pharmacotherapy for Irritable Bowel Syndrome

• New therapies in Irritable Bowel Syndrome: what works and when

• Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome

• AAPT Diagnostic Criteria for Chronic Abdominal, Pelvic, and Urogenital Pain: Irritable Bowel Syndrome

• The role of high expectations of self and social desirability in emotional processing in individuals with irritable bowel syndrome: A qualitative study

• Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders

• Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome

• Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response

• General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study

• Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases

• Role of G protein-coupled receptors-microRNA interactions in Gastrointestinal Pathophysiology

• The effect of fiber and prebiotics on children's gastrointestinal disorders and microbiome

• Chronic Urticaria and Irritable Bowel Syndrome: a Cross-Sectional Study of 11,271 Patients

• Complementary and Integrative Gastroenterology

• Chronic Urticaria and Irritable Bowel Syndrome: a Cross-Sectional Study of 11,271 Patients

• Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial

• The global impact of IBS: time to think about IBS-specific models of care?

• Low FODMAP: A Preliminary Strategy to Reduce Gastrointestinal Distress in Athletes

• The place of eluxadoline in the management of irritable bowel syndrome with diarrhea

• Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article

• Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by ?-Galactosidase Treatment

• Irritable bowel syndrome and diet: where are we in 2018?

• Prokinetics in the Management of Functional Gastrointestinal Disorders

• Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease

• Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts

• Clopidogrel IBS Patients Have Higher Incidence of Gastrointestinal Symptoms Influenced by Age and Gender

• Cognitive Behavioral Therapy for IBS: How Useful, How Often, and How Does It Work?

• A psychology of the human brain-gut-microbiome axis

• Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome with Eluxadoline

• Development and validation of the Patient-Physician Relationship Scale among patients with irritable bowel syndrome

• Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but not in the Population

• Advances in IBS 2016: A Review of Current and Emerging Data

• A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset

• Rifamycins, Alone and in Combination

• Modern Management of Irritable Bowel Syndrome: More Than Motility

• British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)

• Irritable bowel syndrome and the perinatal period: lower birth weight increases the risk

• Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment

• Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation

• Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness

• Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome

• Acupuncture for irritable bowel syndrome: 2-year follow-up of a randomised controlled trial

• Gut microbiota role in irritable bowel syndrome: New therapeutic strategies

• Inflammation in irritable bowel syndrome: Myth or new treatment target?

• Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials

• Hot Topics in Primary Care: Individualizing Pharmacologic Management of Irritable Bowel Syndrome

• Is irritable bowel syndrome an infectious disease?

• Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome

• The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study

• Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders

• Rifaximin and Eluxadoline - Newly Approved Treatments for Diarrhea-Predominant Irritable Bowel Syndrome: What is Their Role in Clinical Practice Alongside Alosetron?

• Managing irritable bowel syndrome in primary care

• Probiotics in Irritable Bowel Syndrome: The Science and the Evidence

• New and Emerging Treatment Options for Irritable Bowel Syndrome

• Recommendations for Probiotic Use-2015 Update: Proceedings and Consensus Opinion

• Irritable Bowel Syndrome and Microscopic Colitis: a Systematic Review and Meta-analysis

• Irritable bowel syndrome in patients with quiescent inflammatory bowel disease. A review

• Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the

• Gender differences in irritable bowel syndrome: the interpersonal connection

• Increased Risk of Functional Gastrointestinal Sequelae Following Clostridium difficile infection among Active Duty United States Military Personnel (1998-2010)

• A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms

• Diet low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial

• Diagnostic outcomes following childhood non-specific abdominal pain: a record-linkage study

• Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis

• RIFAXIMIN: THE REVOLUTIONARY ANTIBIOTIC APPROACH FOR IRRITABLE BOWEL SYNDROME

• Prokinetics in the Management of Functional Gastrointestinal Disorders

• Pharmacogenetics in irritable bowel syndrome

• Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity

• Drug discovery approaches to irritable bowel syndrome

• Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults

• Symbiotics in irritable bowel syndrome - better than probiotics alone?

• Disability in Children and Adolescents with Irritable Bowel Syndrome and/or Fibromyalgia

• A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS

• Irritable Bowel Syndrome: Modern Concepts and Management Options

• Irritable bowel syndrome: an integrated explanatory model for clinical practice

• Increased attentional network functioning related to symptom severity measures in females with irritable bowel syndrome

• The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease

• Irritable bowel syndrome: new and emerging treatments

• Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers

• Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina

• Is fructose malabsorption a cause of irritable bowel syndrome?

• Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina

• Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome

• Evidence Against Routine Testing of Patients with Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study

• Current and Emerging Treatments for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: Focus on Prosecretory Agents

• Pediatric Functional Constipation Gastrointestinal Symptom Profile Compared to Healthy Controls

• Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndrome

• Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome

• New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics

• A systematic review of integrated traditional chinese and Western medicine for managing irritable bowel syndrome

• Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology

• Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea

• Obesity and irritable bowel syndrome: a comprehensive review

• Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea

• A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome

• Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

• Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009

• New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin

• The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden

• Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder

• Irritable bowel syndrome: a clinical review

• Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

• High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria

• Abdominal pain endpoints currently recommended by the FDA and EMA for adult patients with irritable bowel syndrome may not be reliable in children

• Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea

• Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

• Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease

• Irritable bowel syndrome: an integrated explanatory model for clinical practice

• A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS

• Irritable Bowel Syndrome: Modern Concepts and Management Options

• Lubiprostone in constipation: clinical evidence and place in therapy

• Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009

• A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome

• Deficient habituation to repeated rectal distensions in irritable bowel syndrome patients with visceral hypersensitivity

• The Science, Evidence and Practice of Dietary Interventions in Irritable Bowel Syndrome

• Mood and Anxiety Disorders in Chronic Fatigue Syndrome, Fibromyalgia, and Irritable Bowel Syndrome: Results From the LifeLines Cohort Study

• The Effect of Emotional Stress and Depression on the Prevalence of Digestive Diseases

• Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study

• Stress and chronic pelvic pain

• Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder

• A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)

• Risk for irritable bowel syndrome in fibromyalgia patients: a national database study

• Chronic multisymptom illness among female veterans deployed to iraq and afghanistan

• The rise and fall of gluten!

• Functional gastrointestinal disorders in 35 447 adults and their association with body mass index

• IBS-like symptoms in patients with ulcerative colitis

• Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

• Nonpharmacologic Treatment of Functional Abdominal Pain Disorders: A Systematic Review

• Rifaximin: irritable bowel syndrome

• Complementary and Alternative Medicine Use Is Prevalent Among Patients with Gastrointestinal Diseases

• Genetic polymorphism in pathogenesis of irritable bowel syndrome

• Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report

• Perceived risk as a barrier to appropriate diagnosis of irritable bowel syndrome